# Tesseract Medicines

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tesseract-medicines

- Industry: Biotechnology
- Headquarters: Newton, US
- Total disclosed funding: $20M
- Latest round: Seed (Jun 10, 2024)
- Investors on record: 3

## About

Founded in 2022 and based in Massachusetts, US, Tesseract Medicines provides biopharmaceutical drugs for treating cancer. In June 2024, investors Curie.Bio, Chengwei Capital, and Gordian Ventures co-led a USD 20 million Seed funding for Tesseract Medicines.

The company sells antibody-drug conjugates, which are biopharmaceutical medications used to treat cancer. It is designed to benefit from intracellular proteins specific to cancer and anti-drug conjugates, which are biopharmaceutical drugs used in cancer treatment.

The company offers novel therapeutics that help in exploiting cancer–specific intracellular proteins.

## Funding rounds

- Seed, Jun 10, 2024, $20M — Chengwei Capital, Gordian Ventures, Curie.Bio

## Investors

- Chengwei Capital (https://capitalatlas.ai/funds/chengwei-capital) — Seed
- Gordian Ventures — Seed
- Curie.Bio (https://capitalatlas.ai/funds/curie-bio) — Seed